Medications such as semaglutide (Ozempic, Wegovy) or tirzepatide have revolutionized obesity treatment. Many women lose a significant amount of weight with them, and comparatively quickly, without the typical hormonal counter reactions seen with classic diets. Even so, hormone balance can change during GLP 1 therapy as well. The key is understanding what changes, why it happens, and which effects are considered typical from a scientific perspective.
Why does the body react so strongly to dieting?
With a large calorie deficit, the body normally tries to defend its weight. This happens through:
- A drop in the satiety hormone leptin
- An increase in the hunger hormone ghrelin
- A reduction in active thyroid hormones (T3)
- Higher cortisol levels
- Cycle changes due to low energy availability
These mechanisms are well established and are one reason why classic crash diets often fail or trigger the well known “yo yo effect.”
Why GLP 1 medications blunt these hormonal issues
GLP 1 analogs act centrally in the brain and in the digestive tract. They help ensure that hunger and appetite do not spike, even when energy intake is reduced.
1. Ghrelin increases much less under GLP 1
Normally, hunger would increase significantly. With semaglutide, that often does not happen, because the GLP 1 signaling pathway inhibits ghrelin release and strengthens central satiety signaling.
Studies show: semaglutide reduces subjective appetite and prevents the “rebound hunger” that often accompanies classic diets.
2. Leptin decreases, but patients tend to notice it less
Leptin always decreases with weight loss, but GLP 1 medications prevent that drop from immediately leading to cravings or strong food urges. Leptin resistance may even improve as a result of weight loss.
3. Thyroid hormones are more stable than with crash diets
Research shows that metabolism declines less under GLP 1 therapy than with conventional diets, even though fewer calories are consumed. The reason: less hunger related stress, a more stable energy supply, and a lower cortisol burden.
4. Less stress on the menstrual cycle
Rapid weight loss can affect the menstrual cycle in general. Under GLP 1 therapy, the risk is lower because the body does not run the same “alarm program” as with very restrictive diets. Still, very rapid weight loss can have an effect here as well, just overall to a lesser degree.
What women should pay attention to despite medication
- Enough protein to prevent muscle loss
- Regular meals, even if hunger is reduced
- No extremely low energy intake
- Strength training alongside treatment
- Monitor your cycle and overall well being
GLP 1 medications help, but a hormone friendly lifestyle remains essential.
Conclusion
Rapid weight loss is usually associated with pronounced hormonal counter reactions. With GLP 1 medications, these effects are measurably blunted, because hunger regulation, appetite control, and stress hormones remain more stable. This helps explain why many women lose weight more successfully and sustainably on semaglutide. Still, it is worth taking a mindful look at nutrition, muscle preservation, and hormonal balance so the therapy remains effective over the long term.
Sources
- Rosenbaum, M., & Leibel, R. L. (2010). Adaptive thermogenesis in humans. New England Journal of Medicine.
- Müller, M. J. et al. (2016). Metabolic adaptation to weight loss. Obesity Reviews.
- Tomiyama, A. J. et al. (2010). Effects of dieting on cortisol. Psychosomatic Medicine.
- De Souza, M. J. et al. (2014). Female Athlete Triad. British Journal of Sports Medicine.
- Blundell, J. et al. (2017). Semaglutide effects on appetite and energy intake. Diabetes, Obesity and Metabolism.
- Rubino, D. et al. (2021). Semaglutide and weight loss mechanisms. New England Journal of Medicine.